Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 344.10
-7.00 (-1.99%)
At close: Feb 12, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 4.45 billion as of February 13, 2026. Its market cap has decreased by -21.83% in one year.
Market Cap
4.45B
Enterprise Value
4.40B
Revenue
1.70B
Ranking
n/a
PE Ratio
46.94
Stock Price
344.10
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 4.45B, an increase of 4,000.15%. That is a compound annual growth rate of 19.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.45B | -3.64% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kopran | 6.48B |
| Sudarshan Pharma Industries | 6.18B |
| Kilitch Drugs (India) | 5.80B |
| Jenburkt Pharmaceuticals | 4.66B |
| Albert David | 4.31B |
| Medico Remedies | 3.95B |
| Everest Organics | 3.90B |
| Amanta Healthcare | 3.73B |